TITLE

Obesity Management in Primary Care

AUTHOR(S)
Logue, Everett E.; Smucker, William D.
PUB. DATE
June 2001
SOURCE
Journal of Family Practice;Jun2001, Vol. 50 Issue 6, p520
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article comments on the obesity management in primary care. It informs that despite their high prevalence, obesity and obesity- related diseases are underdiagnosed and undertreated by family physicians. Possible barriers to changing the status quo of obesity management include concern that patients are uncomfortable with a more proactive approach. It stresses that there were no important differences between lean, overweight, or obese patients in their strong preferences for exercise or dietary recommendations. Patients also wanted help setting realistic weight goals. Physicians should remember that even a 10% decrease in weight would produce medically important decreases in blood pressure, blood lipids, or blood glucose.
ACCESSION #
4858593

 

Related Articles

  • Many patients with DM missing lipid targets, missing treatment.  // PharmacoEconomics & Outcomes News;4/7/2007, Issue 525, p7 

    The article discusses research being done on lipid targets and lipid-lowering therapy in patients with diabetes mellitus in Australia. It references a study by M. C. Thomas and colleagues, published in the February 2007 issue of the "Medical Journal of Australia." The study examined how often...

  • Clinical: Hyperlipidaemia.  // GP: General Practitioner;11/11/2005, p58 

    The article presents information on the treatment of hyperlipidaemia. It is informed that familial combined hyperlipidaemias are common, and are a genetically heterogeneous group of disorders presenting with isolated or mixed hyperlipidaemias and moderate family histories of CHD. Familial...

  • Combined dyslipidemia with a focus on current and emerging therapeutic approaches. Davidson, Michael H. // Hot Topics in Cardiometabolic Disorders;2011, Vol. 2 Issue 3, p17 

    As the population becomes more obese and the prevalence of diabetes and metabolic syndrome increases, lowdensity lipoprotein cholesterol (LDL-C) is increasingly losing its value as a sole predictor for cardiovascular (CV) risk. In addition, targeting LDL-C treatment to <70 mg/dL has achieved...

  • Cholesterol-rich diet induced improvement of hemodynamic system indices in SHR. Portnichenko, G. V.; Goncharov, S. V.; Stroy, D. O.; Dosenko, V. E. // Fiziologichnyi Zhurnal (Physiological Journal);2019, Vol. 65 Issue 2, p68 

    Metabolic syndrome is the nowadays problem that arose as a result of changes in lifestyle and diet. Several of the key factors of this disorder are lipid metabolism disturbances and hypertension. However, there is little known about combined influence of this factors and their contribution to...

  • hyperlipidaemia.  // Royal Society of Medicine: Medicines;2002, p292 

    The article presents information on hyperlipidaemia, a clinical condition where the blood plasma contains very high levels of the lipids cholesterol and/or triglycerides. Deposition of lipids onto the lining of blood vessels leads to diseases such as coronary atherosclerosis where plaques of...

  • Lipid Synthesis in Cutaneous Xanthoma. Hu, Chung-Hong; Ellefson, Ralph D.; Winkelmann, R. K. // Journal of Investigative Dermatology;Aug82, Vol. 79 Issue 2, p80 

    In vitro lipogenesis was studied on the xanthoma tissue from 6 patients with normal plasma lipids and 4 patients with hyperlipidemia. Xanthoma tissue was incubated at 37°C for 6 hr in Krebs-Ringer phosphate buffer containing sodium [14C]acetate. The radioactivity of each lipid class...

  • Lescol XL.  // Royal Society of Medicine: Medicines;2002, p328 

    The article presents information on Lescol XL, a proprietary, prescription-only preparation of the lipid-regulating drug fluvastatin. It can be used in hyperlipidaemia to change the proportions of various lipids in the bloodstream. It is available as modified-release tablets.

  • Lipitor.  // Royal Society of Medicine: Medicines;2002, p334 

    This article presents information on Lipitor which is a proprietary, prescription-only preparation of the lipid-regulating drug atorvastatin. It can be used in hyperlipidaemia to change the proportions of various lipids in the bloodstream.

  • Zocor.  // Royal Society of Medicine: Medicines;2002, p578 

    This article presents information on Zocor which is a proprietary, prescription-only preparation of the lipid-regulating drug simvastatin. It can be used in hyperlipidaemia to modify the proportions of various lipids in the bloodstream. It is available as tablets.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics